These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 30134892)

  • 1. Influence of sample collection tube method, anticoagulant-containing plasma versus serum, on influenza virus hemagglutination inhibition titer and microneutralization titer serological assays.
    Morrison BJ; Martin NJ; Rehman T; Ewing D; Dewar RL; Metcalf J; Sun P; Beigel J; Luke TC; Raviprakash K
    BMC Health Serv Res; 2018 Aug; 18(1):651. PubMed ID: 30134892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative analysis of hemagglutination inhibition titers generated using temporally matched serum and plasma samples.
    Defang GN; Martin NJ; Burgess TH; Millar EV; Pecenka LA; Danko JR; Arnold JC; Kochel TJ; Luke TC
    PLoS One; 2012; 7(12):e48229. PubMed ID: 23284613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assay Harmonization and Use of Biological Standards To Improve the Reproducibility of the Hemagglutination Inhibition Assay: a FLUCOP Collaborative Study.
    Waldock J; Zheng L; Remarque EJ; Civet A; Hu B; Jalloh SL; Cox RJ; Ho S; Hoschler K; Ollinger T; Trombetta CM; Engelhardt OG; Caillet C
    mSphere; 2021 Aug; 6(4):e0056721. PubMed ID: 34319129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivated H7 Influenza Virus Vaccines Protect Mice despite Inducing Only Low Levels of Neutralizing Antibodies.
    Kamal RP; Blanchfield K; Belser JA; Music N; Tzeng WP; Holiday C; Burroughs A; Sun X; Maines TR; Levine MZ; York IA
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28768855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel serological assay for influenza based on DiD fluorescence dequenching that is free from observer bias and potentially automatable - A proof of concept study.
    Makarkov AI; Patel AR; Bainov V; Ward BJ
    Vaccine; 2018 Jul; 36(30):4485-4493. PubMed ID: 29929824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low population serum microneutralization antibody titer against the predominating influenza A(H3N2) N121K virus during the severe influenza summer peak of Hong Kong in 2017.
    Zhu H; Lee ACY; Li C; Mak WWN; Chen YY; Chan KH; Zhang AJX; Fung WF; Zhang RQ; Fung YF; Poon RWS; Lam JY; Tam S; Hung IFN; Chen H; Yuen KY; To KKW
    Emerg Microbes Infect; 2018 Mar; 7(1):23. PubMed ID: 29511175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparability of Titers of Antibodies against Seasonal Influenza Virus Strains as Determined by Hemagglutination Inhibition and Microneutralization Assays.
    Heeringa M; Leav B; Smolenov I; Palladino G; Isakov L; Matassa V
    J Clin Microbiol; 2020 Aug; 58(9):. PubMed ID: 32493784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microneutralization assay titres correlate with protection against seasonal influenza H1N1 and H3N2 in children.
    Verschoor CP; Singh P; Russell ML; Bowdish DM; Brewer A; Cyr L; Ward BJ; Loeb M
    PLoS One; 2015; 10(6):e0131531. PubMed ID: 26107625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of influenza-specific neutralizing antibody titers determined using different assay readouts and hemagglutination inhibition titers: good correlation but poor agreement.
    Sicca F; Martinuzzi D; Montomoli E; Huckriede A
    Vaccine; 2020 Mar; 38(11):2527-2541. PubMed ID: 32044163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rate of decline of antibody titers to pandemic influenza A (H1N1-2009) by hemagglutination inhibition and virus microneutralization assays in a cohort of seroconverting adults in Singapore.
    Hsu JP; Zhao X; Chen MI; Cook AR; Lee V; Lim WY; Tan L; Barr IG; Jiang L; Tan CL; Phoon MC; Cui L; Lin R; Leo YS; Chow VT
    BMC Infect Dis; 2014 Jul; 14():414. PubMed ID: 25066592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the Hemagglutination Inhibition Titers against Influenza Vaccine Strains in Japan from the 2017/2018 to 2021/2022 Seasons Using a Single Set of Serum Samples.
    Otani N; Nakajima K; Ishikawa K; Ichiki K; Yoda Y; Ueda T; Takesue Y; Yamamoto T; Tanimura S; Shima M; Okuno T
    Viruses; 2022 Jun; 14(7):. PubMed ID: 35891435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of cross-neutralizing antibody against H5N1 virus after vaccination with seasonal influenza vaccine in COPD patients.
    Kositanont U; Wongsurakiat P; Pooruk P; Maranetra N; Puthavathana P
    Viral Immunol; 2010 Jun; 23(3):329-34. PubMed ID: 20565296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum strain-specific or cross-reactive neuraminidase inhibiting antibodies against pandemic А/California/07/2009(H1N1) influenza in healthy volunteers.
    Desheva YA; Smolonogina TA; Donina SA; Rudenko LG
    BMC Res Notes; 2015 Apr; 8():136. PubMed ID: 25889924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies Against Egg- and Cell-Grown Influenza A(H3N2) Viruses in Adults Hospitalized During the 2017-2018 Influenza Season.
    Levine MZ; Martin ET; Petrie JG; Lauring AS; Holiday C; Jefferson S; Fitzsimmons WJ; Johnson E; Ferdinands JM; Monto AS
    J Infect Dis; 2019 May; 219(12):1904-1912. PubMed ID: 30721982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-reactive immunity against influenza viruses in children and adults following 2009 pandemic H1N1 infection.
    Ahmed MS; Jacques LC; Mahallawi W; Ferrara F; Temperton N; Upile N; Vaughan C; Sharma R; Beer H; Hoschler K; McNamara PS; Zhang Q
    Antiviral Res; 2015 Feb; 114():106-12. PubMed ID: 25513756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and immunogenicity of a seasonal trivalent inactivated split influenza vaccine: a phase I randomized clinical trial in healthy Serbian adults.
    Stevanovic G; Lavadinovic L; Filipovic Vignjevic S; Holt R; Ilic K; Berlanda Scorza F; Sparrow E; Stoiljkovic V; Torelli G; Madenwald T; Socquet M; Barac A; Ilieva-Borisova Y; Pelemis M; Flores J
    Hum Vaccin Immunother; 2018 Mar; 14(3):579-586. PubMed ID: 29239682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computationally Optimized Broadly Reactive Hemagglutinin Elicits Hemagglutination Inhibition Antibodies against a Panel of H3N2 Influenza Virus Cocirculating Variants.
    Wong TM; Allen JD; Bebin-Blackwell AG; Carter DM; Alefantis T; DiNapoli J; Kleanthous H; Ross TM
    J Virol; 2017 Dec; 91(24):. PubMed ID: 28978710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Standardization of Hemagglutination Inhibition Assay for Influenza Serology Allows for High Reproducibility between Laboratories.
    Zacour M; Ward BJ; Brewer A; Tang P; Boivin G; Li Y; Warhuus M; McNeil SA; LeBlanc JJ; Hatchette TF;
    Clin Vaccine Immunol; 2016 Jan; 23(3):236-42. PubMed ID: 26818953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of serum neutralization antibodies against seasonal influenza A strain H3N2 and the emerging strains 2009 H1N1 and avian H5N1.
    Zhang R; Rong X; Pan W; Peng T
    Scand J Infect Dis; 2011 Mar; 43(3):216-20. PubMed ID: 21142624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single radial haemolysis compared to haemagglutinin inhibition and microneutralization as a correlate of protection against influenza A H3N2 in children and adolescents.
    Wang B; Russell ML; Brewer A; Newton J; Singh P; Ward BJ; Loeb M
    Influenza Other Respir Viruses; 2017 May; 11(3):283-288. PubMed ID: 28218983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.